In 2017, the Oklahoma State Department of Education hit the reset button on how the public should interpret state test results. The department called that year “a total reset” that would establish “a ...

Tobi is a crypto writer at Investopedia. He aims to simplify the complex concepts of blockchain and cryptocurrencies for the masses. Houston Cofield/Bloomberg via Getty Images Charlie Munger, who died ...

On July 31, Strategy published equity guidance in its earnings deck stating it would not issue common stock below 2.5x mNAV except to pay interest on debt obligations and fund preferred equity ...

Adam B plays Among Us in real life with extreme impostor IQ. Sotomayor warns of major power shift Three Medicare coverage changes happening next month With the penny going away, what should you do ...

The Fed's resumption of balance sheet expansion objectively benefits the stock market, while simultaneously weakening the US dollar and driving a sustained long-term rise in gold and silver prices, ...

In a 12-page letter to the MSCI Equity Index Committee, Strategy said Bitcoin-treasury firms would "whipsaw on and off" major indexes as market prices shift, arguing the rule would generate ...

Every investor has a moment when a brilliant idea pops into their head and they’re suddenly convinced they’ve cracked the market’s secret code. But ideas are cheap, and markets are not, so the real ...

Liquidation calls from the sidelines are growing louder for Strategy (MSTR) as bitcoin tumbles and the company's common stock has plunged nearly 70% from last year's peak, calling into question — for ...

Schiff also challenged Binance co-founder Changpeng Zhao (CZ) to a debate, slated to take place in December in the United Arab Emirates. Gold investor Peter Schiff called Strategy’s business model, ...

Mudit Singh is the VP of Growth & Product at LambdaTest, an AI-native unified enterprise test execution cloud platform. To address this, more organizations are exploring self-healing agentic test ...

MADISON, Wis., September 10, 2025 — Exact Sciences Corp. (Nasdaq: EXAS), a leader in cancer diagnostics, today announced the launch of the Cancerguard™ test, a new multi-cancer early detection (MCED) ...